Advertisement
Screener

CapsoVision, Inc (CV) Capital Expenditures

2.8 / 5 stars · 68/120 Roast Me

CapsoVision, Inc Capital Expenditures

CapsoVision, Inc (CV) reported Capital Expenditures of $48.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-13

  • CapsoVision, Inc payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
  • CapsoVision, Inc payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $48.00K, a 20.00% increase year-over-year.
  • CapsoVision, Inc payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $8.00K.
  • CapsoVision, Inc payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $12.00K, a 200.00% increase year-over-year.
  • CapsoVision, Inc payments to acquire property, plant, and equipment for fiscal 2025 was $90.00K, a 41.18% decline from fiscal 2024.
  • CapsoVision, Inc payments to acquire property, plant, and equipment for fiscal 2024 was $153.00K.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 6 monthPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 12 month
2026-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
$48.00K
10-Q · filed 2026-08-13
$56.00K
derived: sum of 3 quarters · filed 2026-08-13
$68.00K
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31$48.00K
10-Q · filed 2026-05-14
$56.00K
derived: sum of 2 quarters · filed 2026-05-14
$68.00K
derived: sum of 3 quarters · filed 2026-05-14
$98.00K
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31$8.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
$20.00K
derived: sum of 2 quarters · filed 2026-03-26
$50.00K
derived: sum of 3 quarters · filed 2026-08-13
$90.00K
10-K · filed 2026-03-26
2025-09-30$12.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$42.00K
derived: sum of 2 quarters · filed 2026-08-13
$82.00K
10-Q · filed 2025-11-13
$82.00K
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30$30.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
$70.00K
10-Q · filed 2026-08-13
$70.00K
derived: sum of 3 quarters · filed 2026-08-13
$74.00K
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31$40.00K
10-Q · filed 2026-05-14
$40.00K
derived: sum of 2 quarters · filed 2026-05-14
$44.00K
derived: sum of 3 quarters · filed 2026-05-14
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
$4.00K
derived: sum of 2 quarters · filed 2026-03-26
$153.00K
10-K · filed 2026-03-26
2024-09-30$4.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$153.00K
10-Q · filed 2025-11-13
2024-06-30$149.00K
10-Q · filed 2025-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
Vivani Medical, Inc. (VANI)United States$0.111B
electroCore, Inc. (ECOR)United States$0.102B
Neuraxis, INC (NRXS)United States$0.097B
Nexalin Technology, Inc. (NXL)United States$0.094B
Streamex Corp. (STEX)United States$0.089B-0.19
Outset Medical, Inc. (OM)United States$0.059B-1.09
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B